Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Nalbuphine in Attenuation of Hemodynamic Response to Laryngoscopy and Orotracheal Intubation: A Randomized Controlled Trial

NCT07348159 is registered in ClinicalTrials.gov with Dr. Waseem Ullah as lead sponsor.

NCT NCT07348159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07348159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Nalbuphine in Attenuation of Hemodynamic Response to Laryngoscopy and Orotracheal Intubation: A Randomized Controlled Trial
Lead sponsor
Dr. Waseem Ullah
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2024
Completion date
December 15, 2024
Enrollment
107 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemodynamic response to laryngoscopy and orotracheal intubation